We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...
Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret ...
These are the kinds of stocks long-term investors will often be interested in, since they must have excellent, resilient ...
Merck 2025 Sales Forecast Underwhelms as It ... forecast due partly to a pause in shipments of one of its top-selling products to China. The drugmaker plans to temporarily pause shipments of ...
14d
Hosted on MSNWall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What’s Next?Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name drugs such as Keytruda, and the myriad of commercials the company shows on ...
Stay informed and make well-considered decisions with our Ratings Table. Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic ...
Merck & Co., Inc. operates as a healthcare company ... The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology ...
Karen Andersen, CFA, is a healthcare strategist for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She is r ...
The company said its partner in China, Chongqing Zhifei Biological Products, has stocked up more Gardasil than it can sell. As a result, Merck will stop shipping Gardasil to Zhifei at least until ...
Merck MRK0.16%increase; green up pointing triangle shares tumbled more than 11% Tuesday morning after the drugmaker gave 2025 revenue guidance that fell short of analyst expectations and said it ...
Merck (MRK) announced that the European Commission has conditionally approved WELIREG, Merck’s oral hypoxia-inducible factor-2 alpha inhibitor, ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best blue chip stocks ... a diverse product or service offering, and a history of consistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results